GlassScriptPhysician profile
Heather M Mitzel
NPI 1548299878
$4,510.44
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,456 · 2022: $1,790 · 2023: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.75 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $729.69 | 2021-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $704.17 | 2021-2023 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $550.79 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $467.14 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $414.70 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.28 | 2021-2023 | Jardiance |
| United Therapeutics Corporation | $208.75 | 2021-2023 | Tyvaso, Orenitram, Remodulin |
| Astrazeneca Pharmaceuticals LP | $203.40 | 2021-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $202.63 | 2021-2023 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $168.93 | 2021-2022 | |
| Amgen INC. | $137.58 | 2021-2023 | Repatha |
| Merck Sharp & Dohme LLC | $84.58 | 2022-2023 | Verquvo |
| Lundbeck LLC | $80.22 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $61.92 | 2021 | |
| Novo Nordisk INC | $58.03 | 2023 | Ozempic, Rybelsus |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.95 | 2023 | Injectafer |
| Boston Scientific Corporation | $20.98 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.12 | 2021 | |
| Pfizer INC. | $14.97 | 2022 | |
| Apria Healthcare LLC | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Mitzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.